First separation of commendamide enantiomers

N-(3-hydroxyacyl)glycines are compounds of remarkable interest due to their biogenic origin and bioactivity and as precursors of the corresponding 3-acyloxy derivatives which represent an important class of bioactive products of bacterial origin. Commendamide [N-(3-hydroxypalmitoyl)glycine] (1) is a gut microbiota-derived bioactive metabolite that is structurally like endogenous long-chain N-acyl-amino acids belonging to the endocannabinoidome, a complex lipid signaling system involved in several aspects of mammalian physiology and pathology. Thanks to this structural similarity, this compound and its analogues, like the N-(3-hydroxymyristoyl)glycine 2, exert a remarkable bioactivity in mammals, for instance, through activation of G-protein-coupled receptors (GPCRs). N-(3-Hydroxyacyl)glycines are chiral and the availability of their pure enantiomers may bring light to possible enantioselective pathways within the biological processes which these compounds are involved in. A sustainable synthesis of rac-1 and its analogues was recently reported, but asymmetric synthesis and enantioseparation methods to access their pure or enriched enantiomers were not reported so far. In this paper, we report the first direct separation of commendamide enantiomers by using enantioselective high-performance liquid chromatography (HPLC) with polysaccharide-based chiral columns, aqueous-organic mixtures as mobile phases and either electrospray ionization mass spectrometry (ESI-MS) or UV detection. Optimal enantioseparation was obtained by using an amylose tris(3,5-dimethylphenylcarbamate)-based chiral column and acetonitrile/water 60:40 (v/v) (0.1 % acetic acid) as mobile phase. By adopting the same method, the enantioseparation of the analogue 2 was also performed. The molecular bases of the higher retention and selectivity observed for the N-(3-hydroxyacyl)glycine 1 compared to the analogue 2 were explored by computational analysis.